Avalo Therapeutics, Inc. (AVTX) stock
AVTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.70−0.43 (-6.03%)
Close on Nov 18, 2026Market cap $359.32MP/E –Yield –
Avalo Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Avalo Therapeutics's market cap was $450.18M on Nov 11, 2026, against $338.73M a year earlier. Over the last 5 years it ranged from $1.40M to $1.02B, with a median of $52.15M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $450.18M | +39.1% |
| 2025 | Dec 31, 2025 | $323.75M | +350.0% |
| 2024 | Dec 31, 2024 | $71.94M | +886.2% |
| 2023 | Dec 29, 2023 | $7.29M | -84.6% |
| 2022 | Dec 30, 2022 | $47.41M | -75.2% |
| 2021 | Dec 31, 2021 | $190.79M | -3.4% |
| 2020 | Dec 31, 2020 | $197.59M | -16.8% |
| 2019 | Dec 31, 2019 | $237.56M | +80.9% |
| 2018 | Dec 31, 2018 | $131.30M | +57.6% |
| 2017 | Dec 29, 2017 | $83.31M | +943.6% |
| 2016 | Dec 30, 2016 | $7.98M | +266.1% |
| 2015 | Dec 31, 2015 | $2.18M | – |
See a number that looks wrong?